Evidence map›Paper›PMID 25066739›Full record

ArticleVaccine2014

Apoptosis of antigen-specific CTLs contributes to low immune response in gut-associated lymphoid tissue post vaccination.

Masaru Shimada, Shinji Yoshizaki, Motohide Ichino, Dennis M Klinman, Kenji Okuda

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Masaru ShimadaDepartment of Molecular Biodefense Research, Yokohama City University, Graduate School of Medicine, Yokohama 236-0004, Japan. Electronic address: mshimada@yokohama-cu.ac.jp.
Shinji YoshizakiDepartment of Molecular Biodefense Research, Yokohama City University, Graduate School of Medicine, Yokohama 236-0004, Japan.
Motohide IchinoDepartment of Immunology, Yokohama City University, Graduate School of Medicine, Yokohama 236-0004, Japan.
Dennis M KlinmanCancer and Inflammation Program, National Cancer Institute, Frederick, MD 21702, United States.
Kenji OkudaDepartment of Molecular Biodefense Research, Yokohama City University, Graduate School of Medicine, Yokohama 236-0004, Japan.
Yokohama City University · JPNational Cancer Institute · US

Funding

Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotidesZIABC010852 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KLINMAN, DENNIS · 2009 to 2019
$11.3M
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotideZIABC010853 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KLINMAN, DENNIS · 2009 to 2019
$3.8M
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotideZ01BC010853 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KLINMAN, DENNIS · 2007 to 2008
$701k
Intramural NIH HHS Z01 BC010853
6 · The paper itself

Abstract

The gut-associated lymphoid tissue (GALT) represents a major reservoir of HIV in infected individuals. Vaccines can induce strong systemic immune responses but these have less impact on CD4 T cells activity and numbers in GALT. In this study, we vaccinated mice with an adenovirus vector that expressed the envelope gene from HIV and observed immune responses in the peripheral blood, spleen, liver, mesenteric lymph nodes, and Peyer's patches. We found that (1) the number of HIV-specific CD8 T cells was dramatically lower in GALT than in other tissues; (2) the programmed cell death protein-1 (PD-1) was expressed at high levels in HIV-specific CD8 T cells including memory T cells in GALT; and (3) high levels of HIV-specific CD8 T cell apoptosis were occurring in GALT. These results suggest that contributing to GALT becoming an HIV reservoir during infection is a combination of exhaustion and/or dysfunction of HIV-specific CTLs at that site. These results emphasize the importance of developing of an effective mucosal vaccine against HIV.

Indexed as

AnimalsApoptosisCD8-Positive T-LymphocytesFemaleHIV InfectionsIntestinal MucosaLymphoid TissueMiceMice, Inbred BALB CProgrammed Cell Death 1 ReceptorT-Lymphocytes, CytotoxicProgrammed Cell Death 1 ReceptorMouseProgrammed cell death protein-1 (PD-1)VaccineVirus vector

Identifiers

PMID25066739
PMCPMC6334775
OpenAlexW2015224316

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.